Respondent demographics divided by region of fellowship training and region of current practice
| Fellowship region | Total | Practice region | |||||||
| Northeast | Midwest | South | West | Northeast | Midwest | South | West | ||
| Total respondents | 55 | 46 | 71 | 22 | 194 | 47 | 37 | 65 | 45 |
| Practice setting | |||||||||
| University based (n (%)) | 42 (22) | 34 (18) | 43 (22) | 11 (6) | 130 (67) | 38 (20) | 26 (13) | 44 (23) | 22 (11) |
| Community based (n (%)) | 13 (7) | 12 (6) | 28 (14) | 11 (6) | 64 (33) | 9 (5) | 11 (6) | 21 (11) | 23 (12) |
| Year of fellowship graduation | |||||||||
| Mean | 2001 | 2014 | 2013 | 2014 | 2003 | 2001 | 2003 | 2005 | 2005 |
| SD | 12 | 2 | 2 | 2 | 11 | 11 | 11 | 10 | 10 |
| Range | 1976–2016 | 2011–2016 | 2010–2016 | 2011–2016 | 1974–2016 | 1974–2016 | 1983–2016 | 1979–2016 | 1976–2016 |
| Before 2000 (n (%)) | 24 (12) | 11 (6) | 22 (11) | 8 (4) | 65 (34) | 19 (10) | 15 (8) | 17 (9) | 14 (7) |
| 2000–2009 (n (%)) | 10 (5) | 13 (7) | 29 (15) | 6 (3) | 58 (30) | 17 (9) | 6 (3) | 22 (11) | 13 (7) |
| 2010–2017 (n (%)) | 21 (11) | 22 (11) | 20 (10) | 8 (4) | 71 (37) | 11 (6) | 16 (8) | 26 (13) | 18 (9) |
| No of ovarian cancer patients treated in past 12 months (n (%)) | |||||||||
| ≥25 | 38 (20) | 27 (14) | 43 (22) | 17 (9) | 125 (64) | 30 (15) | 28 (14) | 42 (22) | 25 (13) |
| <25 | 17 (9) | 19 (10) | 28 (14) | 5 (3) | 69 (36) | 17 (9) | 9 (5) | 23 (12) | 20 (10) |
| No LGSC patients treated in past 5 years (n (%)) | |||||||||
| ≥5 | 36 (19) | 29 (15) | 52 (27) | 15 (8) | 132 (68) | 28 (14) | 26 (13) | 48 (25) | 30 (15) |
| <5 | 19 (10) | 17 (9) | 19 (10) | 7 (4) | 62 (32) | 19 (10) | 11 (6) | 17 (9) | 15 (8) |
LGSC, low grade serous ovarian carcinoma.